Whether or not the model proposed by Sonis is correct remains to be elucidated, but it provides a biological basis for testing mucositis intervention. In the past 10 years, more than 25 prophylactic ...

Purpose Issues surrounding the prevention and management of severe oral mucositis in patients with head and neck cancer and patients receiving targeted anticancer therapies are reviewed. Summary ...

Please provide your email address to receive an email when new articles are posted on . Chemo Mouthpiece is designed to cool the oral cavity for the entire duration of chemotherapy treatment. The ...

Gelclair is designed to manage oral mucositis pain by coating and protecting the oral mucosa, aiding in healing and reducing severity. Oral mucositis affects 40% of chemotherapy patients and 90% of ...

The first-in-class uridine phosphorylase inhibitor TK-90 almost completely eliminated severe oral mucositis (SOM) in patients with non-metastatic squamous cell carcinoma of the head and neck who ...

A drug intended to reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis showed promising results in a recent clinical trial. Patients treated with the drug had ...

The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer. The Food and Drug Administration (FDA) granted a ...

UB researchers and collaborators have completed a series of studies that reveal how much painful mouth sores known as oral mucositis increase infection risks in stem cell transplant patients and how ...

Oral mucositis is a side effect of radiation therapy to the head and neck. Symptoms of oral mucositis include dry mouth, thick saliva, mouth ulcers, bleeding, difficulty swallowing, talking, eating, ...